Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Oppenheimer
Oppenheimer analyst Kostas Biliouris lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
